InsiderTrades.com logo
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

IPD Insider Trading

Insider Ownership Percentage: 8.98%
Insider Buying (Last 12 Months): A$448,041.67
Insider Selling (Last 12 Months): A$0.00

ImpediMed Insider Trading History Chart

This chart shows the insider buying and selling history at ImpediMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ImpediMed Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for IPD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
I put all the details together for you here — but please hurry. 

ImpediMed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2024Christine Emmanuel-DonnellyInsiderBuy295,000A$0.05A$15,930.00
9/5/2024Andrew GrantInsiderBuy600,000A$0.05A$28,800.00
8/30/2024Andrew GrantInsiderBuy1,000,000A$0.05A$50,000.00
5/14/2024Christine Emmanuel-DonnellyInsiderBuy100,000A$0.08A$8,000.00
5/8/2024Janelle DelaneyInsiderBuy634,177A$0.08A$50,099.98
5/6/2024Andrew GrantInsiderBuy100,000A$0.08A$8,100.00
3/25/2024Janelle DelaneyInsiderBuy568,181A$0.09A$49,999.93
3/22/2024Janelle DelaneyInsiderBuy581,395A$0.09A$49,999.97
3/4/2024Janelle DelaneyInsiderBuy1,137,634A$0.09A$100,111.79
2/29/2024Andrew GrantInsiderBuy100,000A$0.87A$87,000.00
12/13/2023Christine Emmanuel-DonnellyInsiderBuy67,857A$0.14A$9,499.98
12/4/2023Andrew GrantInsiderBuy70,000A$0.14A$9,660.00
11/1/2023Christine Emmanuel-DonnellyInsiderBuy100,000A$0.11A$10,500.00
6/20/2023David AndersonInsiderBuy920,000A$0.16A$144,440.00
6/13/2023Donald (Don) WilliamsInsiderBuy1,000,000A$0.16A$158,000.00
4/27/2023Donald (Don) WilliamsInsiderBuy100,000A$0.18A$17,500.00
4/20/2023Richard ValenciaInsiderBuy410,000A$0.13A$51,660.00
3/30/2023Donald (Don) WilliamsInsiderBuy100,000A$0.11A$11,000.00
3/27/2023Richard ValenciaInsiderBuy400,000A$0.14A$54,000.00
3/16/2023Donald (Don) WilliamsInsiderBuy100,000A$0.06A$5,800.00
3/6/2023Richard ValenciaInsiderBuy1,000,000A$0.06A$64,000.00
2/28/2023Donald (Don) WilliamsInsiderBuy100,000A$0.06A$6,000.00
10/28/2022Janet WestInsiderBuy500,000A$0.09A$45,000.00
See Full Table
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for ImpediMed (ASX:IPD)

16.29% of ImpediMed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ImpediMed logo
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Read More on ImpediMed

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

1,616,138 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

3.28%

Beta

2.86

Who are the company insiders with the largest holdings of ImpediMed?

ImpediMed's top insider shareholders include:
  1. Andrew Grant (Insider)
  2. Christine Emmanuel-Donnelly (Insider)
  3. David Anderson (Insider)
  4. Donald (Don) Williams (Insider)
  5. Janelle Delaney (Insider)
  6. Richard Valencia (Insider)
Learn More about top insider investors at ImpediMed.
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.